SMS Pharmaceuticals reports robust Q2FY24 operational performance
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
The collaboration brings a seamless digital experience to more formulators worldwide
PhytoSquene now available for clinical and commercial use
Lack of technology transfer stands out as a formidable barrier
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Lupin enters into BTA with Lupin Manufacturing Solutions
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Subscribe To Our Newsletter & Stay Updated